Trastuzumab pamirtecan versus chemotherapy in patients with previously treated, human epidermal growth factor receptor 2 (HER2)-expressing, recurrent endometrial cancer: the phase 3 Fern-EC-01 trial (BNT323-01/GOG-3105/ENGOT-EN25)

International Journal of Gynecological Cancer · Elsevier

Аннотация

Publication date: Available online 19 November 2026 Source: International Journal of Gynecological Cancer Author(s): Floor J. Backes, John McGrane, Bhavana Pothuri, Susie K.S. Lau, Keri-Lee Geneser, Michalis Liontos, Jae-Hoon Kim, Peng-Hui Wang, Xiaohua Wu, Ram Eitan, Monika Ducceschi, Joannie Neveu, Stephan Polterauer, Vicky L.M.N. Soomers, Iris Baelee, Zifang Guo, Hua Mu, Kathleen N. Moore, Hanna Dahlstrand

Читать у издателя →

Похожие статьи